Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Invest Radiol. 2021 Jun 1;56(6):357–368. doi: 10.1097/RLI.0000000000000751

Table 2B.

Structural abnormalities: Intermethod agreement between Original MRI and AFSMRI

Intermethod Agreement
Reader 1 Reader 2 Reader 3
Structure P value* kappa values** P value* kappa values** P value* kappa values**
Menisci 0.5 0.76(0.66–0.85) 0.8 0.71(0.6–0.83) 0.1 0.57(0.45–0.69)
Cruciate Ligaments 0.7 0.84(0.69–0.99) 0.2 0.69(0.48–0.9) 0.9 0.44(0.24–0.64)
Collateral Ligaments 0.5 0.87(0.75–0.99) 0.2 0.58(0.38–0.78) 0.4 0.18(−0.02–0.39)
Tendons (quadriceps / patellar) 0.8 0.94(0.83–1) 0.003 0.16(−0.34–0.66) 0.1 0.16(−0.14–0.46)
Cartilage (femur, tibia, and patella) 0.4 0.35(0.17–0.51) 0.6 0.25(0.1–0.4) 0.02 0.28(0.16–0.4)
Bone marrow abnormalities (edema and fracture) 0.6 0.62 (0.55–0.7) 0.6 0.59(0.51–0.67) 0.4 0.4(0.3–0.51)
*

Wilcoxon Rank test;

**

Cohen’s kappa values, with 95% confidence intervals in parentheses;

Data were dichotomized into defect (partial and full thickness) and no-defect (normal) groups.